Immunological responses to thermal injury

Burns

Volumn 23, Issue 2, 1997, Pages 106-113

  Sparkes, B G ^a  

^a Panmed International   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; CYTOKINE; HEAT SHOCK PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

B LYMPHOCYTE; HELPER CELL; HUMAN; IMMUNE RESPONSE; MACROPHAGE; PROTEIN LIPID INTERACTION; REVIEW; SEPSIS; T LYMPHOCYTE; THERMAL INJURY;

EID: 0030906003     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(96)00089-7     Document Type: Article

References (83)

1. Branch CD, Wilkins CF, Ross FP. The coagulum contact method of skin grafting in the treatment of burns and wounds. Surgery 1945; 19: 460.
2. Munster AM. Alterations of the host defence mechanism in burns. Surg Clin North Am 1970; 50: 1217.
3. Winkelstein A. What are the immunological alterations induced by burn injury? J Trauma 1984; 24: S71.
4. Bone RC. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 1992; 268: 3452.
5. Anonymous. American College of Chest Physicians/Society of Critical Care Medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864.
6. Bone RC. Definitions for sepsis and organ failure. JAMA 1993; 270: 939.
7. Demling RH. Burns. N Engl J Med 1985; 313: 1389.
8. Bardeen CR. A review of the pathology of superficial burns. John Hopkins Hosp Rep 1898;7: 137.
9. Harris BH, Gelfand JA. The immune response to trauma. Semin Pediatr Surg 1995; 4: 77.
10. Struzyna J, Pojda Z, Braun B, Chomicka M, Soiczewska E, Wrembel J. Serum cytokine levels (IL-4, IL-6, IL-8, G-CSF, GM-CSF) in burned patients. Burns 1995; 21: 437.
11. Munster AM. Alteration of the immune system in burns and implications for therapy. Eur J Pediatr Surg 1994; 4: 231.
12. Barlow Y. T lymphocytes and immunosuppression in the burned patient. A review. Burns 1994; 20: 487.
13. Brom J, Koller M, Schluter B, Muller-Lange P, Ulrich-Steinau H, Konig W. Expression of the adhesion molecule CD11b and polymerization of actin by polymorphonuclear granulocytes of patients endangered by sepsis. Burns 1995; 21: 427.
14. Bull JP. Revised analysis of mortality due to burns. Lancet 1971; ii: 1133.
15. Edelson RL, Fink JM. The immunologic function of skin. Scient Amer 1985; 252: 46.
16. Hiebert JM, McGough M, Roeheaver G. The influence of catabolism on immunocompetence in burned patients. Surgery 1979; 86: 242.
17. Schoenenberger GA. Burn toxins isolated from mouse and human skin. Monogr Allergy 1975; 9: 72.
18. Allgower M, Burri C, Gruber UL, Nagel G. Toxicity of burned mouse skin in relation to burn temperature. Surg Forum 1963; 14: 37.
19. Schoenenberger GA, Bauer UR, Cueni LB, Eppenberger U, Allgower M. Isolation and characterization of a cutaneous lipoprotein with lethal effects produced by thermal energy in mouse skin. Biochem Biophys Res Commun 1971; 42: 975.
20. Feifel H, Bruchelt G, Schmidt K. Effect of constituents of burned skin and in vivo skin burning on the respiratory activity of rat liver mitochondria. Burns 1992; 18: 308.
21. Sepulchre C, Moati F, Miskulin M, Huisman O, Moczar E, Robert A-M et al. Biochemical and pharmacological properties of a neurotoxic protein isolated from the blood serum of heavily burned patients. J Pathol 1979; 127: 137.
22. Moati F, Sepulchre C, Miskulin M, Huisman O, Moczar E, Robert AM et al. Biochemical and pharmacological properties of a cardiotoxic factor isolated from the blood serum of burned patients. J Pathol 1979; 127: 147.
23. Rocha M, Silva E, Rosenthal SR. Release of pharmacologically active substances from the rat's skin in vivo following thermal injury. J Pharmacol Exp Ther 1961; 132: 110.
24. Hiramatsu M, Izawa Y, Hagahara M. Serum lipid peroxide levels of patients suffering from thermal injury. Burns 1984; 11: 111.
25. Sparkes BG, Monge G, Marshall S, Peters W, Allgower M, Schoenenberger G. Plasma levels of cutaneous burn toxin and lipid peroxides in thermal injury. Burns 1990; 16: 118.
26. Sparkes BG, Gyorkos J, Gorzcynski R, Brock A. Comparison of endotoxins and cutaneous burn toxin as immunosuppressants. Burns 1990; 16: 123.
27. Schoenenberger GA, Burkhardt F, Kalberer F, Muller W, Stgadtler K, Vogt P et al. Experimental evidence for a significant impairment of host defense for gram-negative organisms by a specific cutaneous toxin produced by severe burn injuries. Surg Gynecol Obstet 1975; 141: 555.
28. Heberer M, Allgower M, Durig M, Beutler P, Hasler P, Schoenenberger GA. Chemoluminescence of phagocytic cells following incubation of whole blood with human burn toxin. Eur Surg Res 1982; 14: 107.
29. Allgower M, Graf M, Hasler P. Evidence of possible involvement of a cutaneous burn toxin in the late burn disease/mortality. Bull Clin Rev Burn Inj 1984; 1: 27.
30. Scholmerich J, Kremer B, Richter IE, Schmidt K, Setyadharma H, Schoenenberger GA. Effect of cutaneous human or mouse burn toxin on the metabolic function of isolated liver cells. Scand J Plast Reconstr Surg 1979; 13: 223.
31. Kremer B, Allgower M, Scheidegger AM, Schmidt KH, Scholmerich J, Wust B et al. Toxin-specific ultrastructural alterations of the mouse liver after burn injuries and the possibility of a specific antitoxic therapy. Scand J Plast Reconstr Surg 1979; 13: 217.
32. Sparkes BG, Teodorczyk-Injeyan J, Peters W, Falk R. Mediators affecting IL2 function in burn immunosuppression. In: Paubert-Braquet M, Braquet P, Demling R, Fletcher R, Foegh M, eds. Lipid Mediators in Immunology of Shock: Burns and Sepsis. New York: Plenum, 1987; p 337. NATO ASI Series; vol 139.
33. Peterson VM, Rundus C. In vitro granulopoietic defects modulated by cutaneous burn toxin. Proc Am Burn Assoc 1985; 17: (abstr 69).
34. Sparkes BG. Influence of burn-induced lipid-prorein-complex on IL2 secretion by PBMC in vitro. Burns 1991; 17: 129.
35. Ninneman JL, Stein MD. Suppression of in vitro lymphocyte response by 'burn toxin' - isolates from thermally injured skin. Immunol Lett 1981; 2: 339.
36. Monge G, Sparkes BG, Allgower M, Schoenenberger GA. Influence of burn-induced lipid-protein complex on IL1 secretion by PMBC in vitro. Burns 1991; 17: 269.
37. Drost A, Burleson D, Cioffi W. Plasma cytokines following thermal injury and their relationship with mortality, burn size and time postburn. J Trauma 1993; 35: 335.
38. Demling RH, Lalonde C. Early burn excision attenuates the postburn lung and systemic response to endotoxin. Surgery 1990; 108: 28.
39. Allgower M, Schoenenberger GA, Sparkes BG. Burning the largest immune organ. Burns 1995; 21 (Suppl 1).
40. Asarnow DM, Kuziel WA, Bonyhadi M, Tigelaar RE, Tucker PW, Allison JP. Limited diversity of γδ antigen receptor genes of Thy-1 dendritic epidermal cells. Cell 1988; 55: 837.
41. Qureishi T, Nagarwalla N, Sarela A, Ahmed AR. Antibodies to the 70-kDa heat-shock protein in patients with thermal burns. Clin Immunol Immunpathol 1995; 75: 94.
42. Dobke MK, Deitch EA, Harnar TJ, Baxter CR. Oxidative activity of polymorphonuclear leukocytes after thermal injury. Arch Surg 1989; 124: 856.
43. Cioffi WG, Burleson DG, Jordan BS, Mason AD, Pruitt BA, Granulocyte oxidative activity after thermal injury. Surgery 1992; 112: 860.
44. Wood J, Rodrick M, O'Mahony J, Palder S, Saporoschitz L, Deon P et al. Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns. Ann Surg 1984; 200: 311.
45. Teodorczyk-Injeyan J, Sparkes BG, Mills GB, Peters W, Falk R. Impairment of T cell activation in burn patients: a possible mechanism of thermal injury-induced immunosuppression. Clin Exp Immunol 1986; 65: 570.
46. Liu X-S, Yang Z-C, Luo Z-H, Li A. Clinical significance of the change of blood monocytic interleukin-1 production in vitro in severely burned aptients. Burns 1994; 20: 302.
47. Teodorczyk-Injeyan J, Sparkes BG, Mills GB, Peters W, Falk R. Impaired expression of interleukin 2 receptor (IL 2R) in the immunosuppressed burn patient. Reversal by exogenous IL 2. J Trauma 1987; 27: 180.
48. Teodorczyk-Injeyan J, Sparkes BG, Mills G, Peters W, Falk R. Increase of serum interleukin 2 receptor level in thermally injured patients. Clin Immunol Immunpathol 1989; 51: 205.
49. Teodorczyk-Injeyan J, Sparkes BG, Peters W. Serum interleukin 2 receptor as a possible mediator of post-burn immunosuppression. J Burn Care Rehabil 1989; 10: 112.
50. Teodorczyk-Injeyan J, Sparkes BG, Mills G, Peters W. Immunosuppression follows systemic T lymphocyte activation in the burn patient. Clin Exp Immunol 1991; 85: 515.
51. Teodorczyk-Injeyan J, Sparkes BG, Peters W. Soluble interleukin 2-receptor α secretion is related to altered interleukin 2 production in thermally injured patients. Burns 1991; 17: 290.
52. Teodorczyk-Injeyan J, Sparkes BG, Falk R, Peters W, Mills G. Interleukin-2 secretion and transmembrane signalling in burned patients. J Trauma 1988; 28: 152.
53. Golstein P, Ojcius DM, Young JD-E. Cell death mechanisms and the immune system. Immunol Rev 1991; 121: 29.
54. Mountz JD, Zhou T, Wu J, Wang W, Su X, Cheng J. Regulation of apoptosis in immune cells. J. Cell Immunol 1995; 15: 1.
55. Sellins KS, Cohen JJ. Hyperthermia induces apoptosis in thymocytes. Radiat Res 1991; 126: 88.
56. Baxter GD, Lavin MF. Specific protein dephosphorylation in apoptosis induced by ionizing radiation and heat shock in human lymphoid tumor lines. J Immunol 1992; 148: 1949.
57. Migliorati G, Nicoletti I, Crocicchio F, Pagliacci C, D'Adamio F, Riccardi C. Heat shock induces apoptosis in mouse thymocytes and protects them from glucocorticoid-induced cell death. Cell Immunol 1992; 143: 348.
58. Teodorczyk-Injeyan JA, Cembrzynska-Nowak MC, Lalani S, Peters WJ, Mills GB. Immune deficiency following thermal trauma is associated with apoptotic cell death. J Clin Immunol 1995; 15: 318.
59. Lenardo MJ. Interleukin 2 programs mouse αβ T lymphocotes for apoptosis. Nature 1991; 353: 858.
60. Demling RH, Lalonde C. Identification and modifications of the pulmonary and systemic inflammatory and biochemical changes caused by a skin burn. J Trauma 1990; 30: S57.
61. Deitch EA, Berg RD. Endotoxin but not malnutrition promotes bacterial translocation of the gut flora in burned mice. J Trauma 1987; 27: 161.
62. Yao T-M, Yu Y, Sheng C-Y, Tian H-M, Wang Y-P, Lu L-R et al. Role of gut-derived endotoxaemia and bacterial translocation in rats after thermal injury: effects of selective decontamination of the digestive tract. Burns 1995; 21: 580.
63. Jones WG, Barber AE, Minei JP, Fahey TJ, Shires GTI, Shires GT. Antibiotic prophylaxis diminishes bacterial translocation but not mortality in experimental burn wound sepsis. J Trauma 1990; 30: 737.
64. Munster AM, Xiao G-X, Guo Y, Wong LA, Winchurch RA. Control of endotoxemia in burn patients by use of polymyxin B. J Burn Care Rehabil 1989; 10: 327.
65. Munster AM, Winchurch RA, Thupari JN, Ernst CB. Reversal of postburn immunosuppression with low-dose Polymyxin B. J Trauma 1986; 26: 995.
66. Guo Y, Dickerson C, Chrest FJ, Adler WH, Munster AM, Winchurch RA. Increased levels of circulating interleukin 6 in burn patients. Clin Immunol Immunopathol 1990; 54: 361.
67. Munster AM, Smith-Meek M, Dickerson C, Winchurch R. Translocation. Incidental phenomenon or true pathology? Ann Surg 1993; 218: 321.
68. Xiao G-X, Chopra RK, Adler WH, Munster A, Winchurch RA. Altered expression of lymphocyte IL2 receptors in burned patients. J Trauma 1988; 28: 1669.
69. Jones EB. Prophylactic anti-lipopolysaccharide freeze-dried plasma in major burns: a double blind controlled trial. Burns 1995; 21: 267.
70. Aulick LH, Wroczynski FA, Madan E, Mason AD. Wound endotoxin is not a principal mediator of postburn hypermetabolism in rats. JTrauma 1990; 30: 457.
71. Tompkins RG, Remensnyder JP, Burk JF. Significant reductions in mortality for children with burn injuries through the use of prompt eschar excision. Ann Surg 1988; 208: 577.
72. Tompkins RG, Burke JF, Schoenfeld DA, Bondoc CC, Quinby WC, Behringer GC et al. Prompt eschar excision: a treatment system contributing to reduced burn mortality. Ann Surg 1986; 204: 272.
73. Herndon DN, Barrow RE, Rutan RL. A comparison of conservative versus early excision. Ann Surg 1989; 209: 547.
74. Monafo WW, Tandon SN, Ayvazian VH. Cerium nitrate, a new topical antiseptic for extensive burns. Surgery 1976; 80: 465.
75. Fox CL, Monafo WW, Ayvazian VH. Topical chemotherapy for burns using cerium salts and silver sulfadiazine. Surg Gynecol Obstet 1977; 144: 668.
76. Monafo WW, Robinson HN, Yoshioka T. Lethal burns. Arch Surg 1978; 113: 397.
77. Gracia CG de, Lucena S. An open comparative study between topical silver sulfadiazine and topical silver sulfadiazine-cerium in the treatment of moderate and severe burns. Proc Eur Burns Assoc 1995; 6: (abstr P6).
78. Kremer B, Allgower M, Graf M, Schmidt KH, Schoelmerich J, Schoenenberger GA. The present status of research in burns toxins. Intensive Care Med 1981; 7: 77.
79. Kistler D, Hafermann B, Schoenenberger GA, Hettich R. Increased survival rates by topical treatment of burns with cerium nitrate. Eur Surg Res 1990; 22: 283.
80. 3 upon a late mortality with respect to cutaneous toxin absorption. Eur Surg Res 1981; 13: 64.
81. Scheidegger D, Sparkes BG, Luscher N, Schoenenberger G, Allgower M. Survival in major burn injuries treated by one bathing in cerium nitrate. Burns 1992; 18: 296.
82. Wasserman D, Schlotterer M, Lebreton F, Levy J, Guefli MC. Use of topically applied silver sulphadiazine plus cerium nitrate in major burns. Burns 1989; 15: 257.
83. Peterson VM, Hansbrough JF, Wang XW. Topical cerium nitrate prevents postburn immunosuppression. J Trauma 1985; 25: 1039.